<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48519">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02474576</url>
  </required_header>
  <id_info>
    <org_study_id>MMN_2015-1</org_study_id>
    <nct_id>NCT02474576</nct_id>
  </id_info>
  <brief_title>Percutaneous Aponeurotomy in the Treatment of Dupuytren's Disease</brief_title>
  <acronym>APADUP</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Groupe Hospitalier Diaconesses Croix Saint-Simon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The efficiency of percutaneous aponeurotomy in the treatment of Dupyutrens disease is well
      known. However, the duration of the clinical improvement after aponeurotomy is not well
      known.

      This study aims primarily at measuring the incidence rate of local relapse of
      Dupuytrens-induced finger flessum, within two years following treatment by percutaneous
      aponeurotomy in Dupuytrens.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of local relapse at 24 months</measure>
    <time_frame>24 months after treatment by aponeurotomy</time_frame>
    <description>the statistical unit is the finger treated by aponeurotomy (we expect an average of 2 fingers treated for one patient included). Local relapse is defined as the recurrence of a finger flessum superior by 20° to the articular range initially obtained after aponeurotomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Primary success rate of aponeurotomy</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>the statistical unit is the finger treated by aponeurotomy (we expect an average of 2 fingers treated for one patient included). Complete success is defined as a finger flessum inferior to 5°</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of local relapse at 12 months</measure>
    <time_frame>12 months after treatment by aponeurotomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of local relapse at 36 months</measure>
    <time_frame>36 months after treatment by aponeurotomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of local relapse at 48 months</measure>
    <time_frame>48 months after treatment by aponeurotomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of local relapse at 60 months</measure>
    <time_frame>60 months after treatment by aponeurotomy</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Dupuytren Disease</condition>
  <arm_group>
    <arm_group_label>Percutaneous aponeurotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment of Dupuytrens-induced finger flessum using percutaneous aponeurotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous aponeurotomy</intervention_name>
    <description>The finger(s) with limited extension due to Dupuytrens disease and for which the patient desires treatment, will be treated by fine-needle percutaneous aponeurotomy under local anesthesia (outpatient procedure). This procedure is already routinely used in clinical practice ; our study aims at better describing the time-sustainability of its benefits.</description>
    <arm_group_label>Percutaneous aponeurotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient suffers from Dupuytren disease

          -  Patient has at least one finger with at least 20° flessum on the metacarpophalangeal
             joint and/or on the proximal interphalangeal joint

          -  Patient has chosen to benefit from local treatment

        Exclusion Criteria:

          -  Pregnancy

          -  Breastfeeding

          -  No social insurance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marie-Pascale Manet-Chopin, MD</last_name>
    <email>mpmanet@hopital-dcss.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Herve Picard, MD</last_name>
    <email>hpicard@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Diaconesses Croix Saint-Simon Hospital Group</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Pascale MANET-CHOPIN, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 17, 2016</lastchanged_date>
  <firstreceived_date>June 12, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
